Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (11 ops.)
Latest filing published 10 Mar 2026 for ANI Pharmaceuticals INC, €96k. Read the official filing
Filing timeline
BuySaleKrista Davis
Insider track record
Disclosed buys
0
Disclosed sells
11
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Krista Davis: trading record in brief
This profile gathers the share dealings of Krista Davis in ANI Pharmaceuticals Inc, where the filings describe the role as senior executive. Over a trading history stretching from 12 September 2022 to 9 March 2026, the count stands at 27 filings.
The open-market record consists of 11 sales worth €1.3M, with no purchase. Besides market trades, the filings include 16 share grants. In 2026 alone, the filings show no purchases and 3 sales.
On 10 March 2026 came the latest disclosure, an open-market sale for €96k in ANI Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Krista Davis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations27 total
1,485 shares@ US$75.000.0054% mcap4.7% of flowCommon StockSEC:0001946439-26-000010:0
5,087 shares@ US$74.130.018% mcap16.1% of flowCommon StockSEC:0001946439-26-000010:1
10,810 shares@ US$77.1524.5% of flowCommon StockSEC:0001946439-26-000008:0
2,084 shares@ US$77.530.0077% mcap20.5% of flowCommon StockSEC:0001946439-26-000006:0
1,180 shares@ US$76.703.8% of flowCommon StockSEC:0001946439-26-000004:0
1,290 shares@ US$77.364.1% of flowCommon StockSEC:0001946439-26-000004:1
3,017 shares@ US$76.256.7% of flowCommon StockSEC:0001946439-26-000002:0
1,622 shares@ US$82.400.0064% mcap17.0% of flowCommon StockSEC:0001946439-25-000019:0
1,000 shares@ US$98.040.0047% mcap12.4% of flowCommon StockSEC:0001946439-25-000017:0
1,710 shares@ US$97.717.2% of flowCommon StockSEC:0001946439-25-000015:0
1,763 shares@ US$91.107.5% of flowCommon StockSEC:0001946439-25-000013:0
1,866 shares@ US$65.005.5% of flowCommon StockSEC:0001946439-25-000010:0
1,000 shares@ US$60.862.8% of flowCommon StockSEC:0001946439-25-000008:0
1,099 shares@ US$61.893.2% of flowCommon StockSEC:0001946439-25-000006:0
1,000 shares@ US$60.202.8% of flowCommon StockSEC:0001946439-25-000004:0
1,196 shares@ US$58.923.3% of flowCommon StockSEC:0001946439-25-000002:2
13,057 shares0Common StockSEC:0001946439-25-000002:0
8,704 shares0Common StockSEC:0001946439-25-000002:1
1,000 shares@ US$60.002.8% of flowCommon StockSEC:0001946439-24-000008:0
1,486 shares@ US$56.153.7% of flowCommon StockSEC:0001946439-24-000006:0
1,173 shares@ US$67.673.6% of flowCommon StockSEC:0001946439-24-000004:0
12,079 shares0Common StockSEC:0001946439-24-000002:0
2,622 shares@ US$53.816.4% of flowCommon StockSEC:0001946439-23-000005:0
1,486 shares@ US$61.914.2% of flowCommon StockSEC:0001946439-23-000003:0
12,158 shares0Common StockSEC:0001104659-23-041721:0
25 of 27 declarations
